Literature DB >> 8386137

Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent.

P W Melkert1, E Hopman, A J van den Brule, E K Risse, P J van Diest, O P Bleker, T Helmerhorst, M E Schipper, C J Meijer, J M Walboomers.   

Abstract

The prevalence of human papillomavirus (HPV) genotypes in relation to age was investigated by the polymerase chain reaction (PCR) method in cytologically normal smears from 4 different groups of women. Group A consisted of young women from a district population, aged 15-34 years, using oral contraceptives and visiting general practitioners for a check-up (n = 156); group B were asymptomatic women, aged 35-55, in a district population participating in a triennial screening program for cervical cancer (n = 1555); group C and D consisted of women, seen at the gynecological outpatient department for a wide spectrum of gynecological complaints or for control of their hormonal contraception, aged 15-34 years (n = 2320), and aged 35-55 years (n = 1826) respectively. An HPV (all types) prevalence of 14.1%, 4.1%, 13.9% and 6.6% and an HPV 16/18 prevalence of 3.8%, 0.9%, 3.3% and 1.5% were found in groups A, B, C and D respectively. Statistically significant differences (p value < 0.001) in HPV prevalence were found between women aged 15-34 years and women aged 35-55 years in the district population and in the hospital population. No statistically significant differences in HPV 16/18 were observed after age-matching between women in corresponding age-classes of both populations. In a 5-year interval analysis a strong age-dependent relationship was demonstrated, with a maximum between 20 and 24 years. After the age of 35 a constant level of 1-2% HPV 16/18 was observed. These results indicate that genital HPV infections are age-dependent and suggest that HPV infections at young age can be transient. The implications of these findings in the context of cervical cancer screening are discussed.

Entities:  

Mesh:

Year:  1993        PMID: 8386137     DOI: 10.1002/ijc.2910530609

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  46 in total

1.  Screening for cervical cancer: should we test for infection with high-risk HPV?

Authors:  C J Meijer; P J Snijders; A J van den Brule
Journal:  CMAJ       Date:  2000-09-05       Impact factor: 8.262

2.  Distribution of 14 high risk HPV types in cervical intraepithelial neoplasia detected by a non-radioactive general primer PCR mediated enzyme immunoassay.

Authors:  I Nindl; B Lotz; R Kühne-Heid; U Endisch; A Schneider
Journal:  J Clin Pathol       Date:  1999-01       Impact factor: 3.411

3.  Detection and typing of human papillomaviruses by polymerase chain reaction in cervical scrapes of Croatian women with abnormal cytology.

Authors:  M Grce; K Husnjak; L Magdić; M Ilijas; M Zlacki; D Lepusić; J Lukac; B Hodek; V Grizelj; A Kurjak; Z Kusić; K Pavelić
Journal:  Eur J Epidemiol       Date:  1997-09       Impact factor: 8.082

4.  Detecting every genital papilloma virus infection: what does it mean?

Authors:  C P Crum
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

5.  Withdrawing low risk women from cervical screening programmes: mathematical modelling study.

Authors:  C Sherlaw-Johnson; S Gallivan; D Jenkins
Journal:  BMJ       Date:  1999-02-06

6.  The planning of cervical cancer screening programmes in eastern Europe: is viral testing a suitable alternative to smear testing?

Authors:  C Sherlaw-Johnson; S Gallivan
Journal:  Health Care Manag Sci       Date:  2000-09

7.  Risk factors for the acquisition of genital warts: are condoms protective?

Authors:  L M Wen; C S Estcourt; J M Simpson; A Mindel
Journal:  Sex Transm Infect       Date:  1999-10       Impact factor: 3.519

Review 8.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

9.  Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic.

Authors:  E I Svare; S K Kjaer; A M Worm; A Osterlind; C J L M Meijer; A J C van den Brule
Journal:  Sex Transm Infect       Date:  2002-06       Impact factor: 3.519

10.  Human papillomavirus infection in Honduran women with normal cytology.

Authors:  N Tábora; J M J E Bakkers; W G V Quint; L F A G Massuger; J A Matute; W J G Melchers; A Ferrera
Journal:  Cancer Causes Control       Date:  2009-08-15       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.